Regulatory Rapporteur January 2011

<< back to list of Issues

Front Cover
Volume 8 Issue 1

In This Issue

  • Back to biotechnology basics
  • Biotech CMC reviewed – 5 years on
  • Are biosimilar MAbs feasible?

Please login to view member only articles. Non-members may download the public articles.

Regulatory Rapporteur January 2011MembersFull Issue2MBPDF
Biotechnology medicinal products: Back to basicsPublic699KBPDF
A regulatory perspective on crisis managementMembers510KBPDF
Building bridges with biotechnologyMembers463KBPDF
EU regulatory updates: October – November 2010Members461KBPDF
European biotechnology CMC regulatory review 2005–2010Members548KBPDF
How can the biosimilar concept be applied to monoclonals?Members501KBPDF
The role of the QPPV in EU veterinary pharmacovigilanceMembers527KBPDF